When Women’s Health Reaches the Prescription, the Pharmacy Benefit Still Has Work to Do

One of the most encouraging changes in women’s health is how much easier it is becoming to find care built around women’s needs.

  • 4 Min read

  • October 22, 2026

Julia Murray, MSN, RN

Julia Murray, MSN, RN

Sr. Dir, Patient Care Advocacy, LucyRx
Best Practices
Woman reviewing healthcare information with a clinician, illustrating the connection between women’s health treatment plans and prescription access.

More women can get help for perimenopause, menopause and other midlife health concerns.

More employers are paying attention. More clinicians and specialty programs are bringing expertise into the conversation.

That is real progress.

But a woman can have a good appointment, leave with a treatment plan she and her clinician agree on, and still get stuck when the prescription reaches the pharmacy benefit.

That is the gap I think we need to pay more attention to.

Clinical access does not automatically create medication access.

The prescription creates a new set of questions

Once a treatment decision has been made, the questions become very practical.

Is the medication covered?

What will she pay?

Does it need prior authorization?

Can her pharmacy get it?

If the prescribed product is not available or affordable, who helps her understand the next step and reconnect with her clinician if another treatment option needs to be considered?

And if something goes wrong, does she know who can help her fix it?

Those may sound like pharmacy benefit questions. To the woman trying to start treatment, they are simply part of her care.

We have seen a real example of this recently. The FDA reported that increased demand was making some estradiol transdermal patches harder to find at certain pharmacies or locations, even though patches remained available overall.¹ A clinician can make an appropriate treatment decision, but that does not guarantee the woman’s usual product will be available when she goes to fill it.

Someone still has to help turn the treatment decision into treatment the woman can actually use.

Midlife can make that job harder

Our own pharmacy data reinforce why this matters.

In a LucyRx book-of-business analysis, women in their 40s and 50s had roughly 50% more prescriptions and about twice the prescription spending of women in their 20s and 30s.³ That does not mean menopause caused the difference. It does tell us that prescription care often becomes more complex in midlife.

A woman may be dealing with menopause symptoms while also managing heart health, metabolic conditions, mental health, sleep or other needs.

She does not experience those as separate benefit categories.

And she should not have to understand which program, formulary rule or pharmacy process owns each part before she can get help.

More women’s health support makes the connections more important

I do not believe the answer is for the pharmacy benefit to try to become the women’s health clinic.

Specialized clinicians and women’s health programs can play an important role. They can help women understand symptoms, evaluate treatment choices and make informed clinical decisions.

The pharmacy benefit has a different job.

When treatment includes a prescription, it should help make that treatment accessible, affordable and usable.

Recent national workplace research found that most employees were not asking employers to buy something new. Instead, they pointed to support many employers already provide, including medical and pharmaceutical coverage.²

That makes the handoff even more important.

A strong clinical solution can still create a poor experience if the member reaches the prescription and finds a coverage rule she did not expect, a price she cannot afford or a medication she cannot find.

More support should make healthcare easier. It should not create more handoffs for the member to manage.

Employers should measure what happens after the prescription

For employers, I would add another set of questions when evaluating women’s health support:

Did members get the treatment their clinician intended?

Could they afford it?

Did they understand what came next?

Where did they get stuck, and how long did it take to resolve the problem?

Did treatment continue, or did a barrier interrupt it?

When an issue crossed between programs or organizations, did someone own the next step?

Those questions tell us more than how many people enrolled in a program or viewed a piece of content. They begin to show whether the benefit worked when the member needed it.

Those are the kinds of measures we should make more visible: whether the intended therapy was filled, member cost, time to resolve access barriers, prior-authorization outcomes and medication continuity.

A paid claim is useful. But it does not tell the whole story.

I started my career as a nurse. One lesson from that work has stayed with me: a care plan only matters if the person can act on it.

The same should be true in benefits.

We have made important progress giving women better clinical choices. Now we need to make sure the rest of the system can keep up with those choices.

When a woman leaves a healthcare conversation with a prescription, that should not be where support ends. It should be where prescription care begins.

Does your pharmacy benefit support the next step in women’s health?

Coverage, affordability and member support all shape what happens after a prescription is written. Connect with LucyRx to explore how your pharmacy benefit can better support women’s health needs and help members move from a treatment plan to treatment they can access.

Tags

Pharmacy Benefit Management Prescription Drug Access Women’s health benefits

Sources

¹ U.S. Food and Drug Administration. “FDA Update on Estradiol Transdermal Patch Availability.” September 3, 2026. The FDA reported increased demand and difficulty accessing usual patches in some pharmacies or locations while noting that estradiol transdermal patches remained available overall. U.S. Food and Drug Administration
URL: https://www.fda.gov/drugs/drug-alerts-and-statements/fda-update-estradiol-transdermal-patch-availability
² Society for Women’s Health Research and The Fuchsia Tent. Menopause at Work: From Echo Chamber to Mainstream Practice, A Report. October 1, 2026. The national study included 1,110 U.S. employees and benefits decision-makers and found that employees generally emphasized existing supports, including medical and pharmaceutical coverage, rather than simply asking employers to buy something new. SWHR
URL: https://swhr.org/resources/menopause-at-work-from-echo-chamber-to-mainstream-practice-a-report
³ LucyRx book-of-business analysis. Women only, trailing 12 months; age-cohort comparison; descriptive and not risk-adjusted. Women in their 40s and 50s averaged approximately 14 prescriptions annually versus 9.4 among women in their 20s and 30s; annual prescription spending averaged approximately $1,204 versus $572. Internal analysis.

Recommended Reads

Business benefits professionals reviewing pharmacy benefit options and partnership requirements for employer health plans.

What Makes a Pharmacy Benefit Solution Easier for TPAs to Stand Behind?

Third-party administrators put their own client relationships at stake when recommending a pharmacy benefit manager. Learn which capabilities help TPAs evaluate PBM partners, explain benefit strategies confidently and maintain accountability from implementation through renewal.
Benefits professionals reviewing pharmacy benefit contract terms, data access and implementation requirements to assess how much control employers have over their PBM strategy.

PBM Flexibility Is Not the Same as Control: What TPAs Should Test

Pharmacy benefit options have limited value if contract restrictions or operational barriers prevent employers from using them. This article outlines how TPAs can assess decision-making information, contractual rights and implementation capabilities before recommending a PBM.
Benefits and implementation teams reviewing a PBM transition plan, data requirements and go-live responsibilities before an employer pharmacy benefit launch.

Implementation Is Part of the Sale: What TPAs Should Test Before Recommending a PBM

A PBM transition can put a TPA’s client relationship at risk if eligibility errors, prescription disruptions or unclear responsibilities emerge at go-live. This checklist outlines five areas TPAs should test before recommending a PBM to an employer.
Employer benefits leader evaluating specialty pharmacy performance, costs, access, and member outcomes

How Should a Specialty Pharmacy Earn Its Role?

Specialty pharmacy can materially affect employer plan costs, access, and treatment continuity. This article outlines the measures benefits leaders can use to evaluate pharmacy channels based on evidence rather than affiliation.

Projected Savings vs. Realized Savings: What Employers Should Ask

Employers need to know whether a pharmacy savings figure represents an opportunity or an actual result. This article explains how to evaluate savings methodology, assumptions, and outcomes.
GLP-1 medication representing employer coverage and cost decisions

A Better Way to Think About GLP-1 Strategy

GLP-1 coverage no longer has to be an all-or-nothing decision. Employers can evaluate access, clinical support, costs, and benefit visibility to build a strategy that works for their plan and the people who rely on it.
Woman with glucose monitor

Diabetes Affordability is About More Than One Prescription

Diabetes affordability extends beyond insulin. Learn how employers can evaluate medication costs, GLP-1s, monitoring devices, coverage rules, and member support across the full diabetes regimen.
Pharmacist and Patient

Is Your Pharmacy Benefit Still Working as Intended?

A pharmacy benefit can perform as designed and still fall behind the market. Learn how employers can evaluate costs, member access, plan design, and PBM performance—and decide whether to stay, improve the current strategy, or explore a change.
Doctors chart

Disclosure Won. Now What?

PBM transparency gives employers greater visibility into pharmacy costs—but disclosure is only the beginning. Learn how plan sponsors can turn better information into greater control, accountability, and measurable results.
Pharmacist and patient

The Human Side of Pharmacy Savings

Savings matter. The person behind each case matters more. How LucyRx Care Guides delivered $2.37 million in savings by starting with one simple thing: listening.
PreviousNext
Business benefits professionals reviewing pharmacy benefit options and partnership requirements for employer health plans.

What Makes a Pharmacy Benefit Solution Easier for TPAs to Stand Behind?

Third-party administrators put their own client relationships at stake when recommending a pharmacy benefit manager. Learn which capabilities help TPAs evaluate PBM partners, explain benefit strategies confidently and maintain accountability from implementation through renewal.
Benefits professionals reviewing pharmacy benefit contract terms, data access and implementation requirements to assess how much control employers have over their PBM strategy.

PBM Flexibility Is Not the Same as Control: What TPAs Should Test

Pharmacy benefit options have limited value if contract restrictions or operational barriers prevent employers from using them. This article outlines how TPAs can assess decision-making information, contractual rights and implementation capabilities before recommending a PBM.
Benefits and implementation teams reviewing a PBM transition plan, data requirements and go-live responsibilities before an employer pharmacy benefit launch.

Implementation Is Part of the Sale: What TPAs Should Test Before Recommending a PBM

A PBM transition can put a TPA’s client relationship at risk if eligibility errors, prescription disruptions or unclear responsibilities emerge at go-live. This checklist outlines five areas TPAs should test before recommending a PBM to an employer.
Employer benefits leader evaluating specialty pharmacy performance, costs, access, and member outcomes

How Should a Specialty Pharmacy Earn Its Role?

Specialty pharmacy can materially affect employer plan costs, access, and treatment continuity. This article outlines the measures benefits leaders can use to evaluate pharmacy channels based on evidence rather than affiliation.

Projected Savings vs. Realized Savings: What Employers Should Ask

Employers need to know whether a pharmacy savings figure represents an opportunity or an actual result. This article explains how to evaluate savings methodology, assumptions, and outcomes.
GLP-1 medication representing employer coverage and cost decisions

A Better Way to Think About GLP-1 Strategy

GLP-1 coverage no longer has to be an all-or-nothing decision. Employers can evaluate access, clinical support, costs, and benefit visibility to build a strategy that works for their plan and the people who rely on it.
Woman with glucose monitor

Diabetes Affordability is About More Than One Prescription

Diabetes affordability extends beyond insulin. Learn how employers can evaluate medication costs, GLP-1s, monitoring devices, coverage rules, and member support across the full diabetes regimen.
Pharmacist and Patient

Is Your Pharmacy Benefit Still Working as Intended?

A pharmacy benefit can perform as designed and still fall behind the market. Learn how employers can evaluate costs, member access, plan design, and PBM performance—and decide whether to stay, improve the current strategy, or explore a change.
Doctors chart

Disclosure Won. Now What?

PBM transparency gives employers greater visibility into pharmacy costs—but disclosure is only the beginning. Learn how plan sponsors can turn better information into greater control, accountability, and measurable results.
PreviousNext

LucyRx is an independent, modern pharmacy benefit manager with the scale of an enterprise serving more than 9 million members nationwide.

Follow us

Linkedin Linkedin Tiktok Tiktok Instagram Instagram
URAC Accreditation

Copyright © 2026 by LucyRx. All Rights Reserved | Privacy Policy | Terms of Use | Members Rights

PBM Flexibility Is Not the Same as Control: What TPAs Should TestBenefits professionals reviewing pharmacy benefit contract terms, data access and implementation requirements to assess how much control employers have over their PBM strategy.Business benefits professionals reviewing pharmacy benefit options and partnership requirements for employer health plans.What Makes a Pharmacy Benefit Solution Easier for TPAs to Stand Behind?

Download the PBM Reform Readiness Checklist

Download the GLP-1 Planning Checklist